Advanced Solid Tumors With and Without Brain Metastases

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Solid Tumors With and Without Brain Metastases trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06136884

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Br…

The purpose of this study is to assess the safety, tolerability and efficacy of the study drug AO-252 and identify the best dose for use in future studies.

United States86 participantsStarted 2023-11-02

Treatment: AO-252

All recent trials (2 shown)

CompletedPhase 1

NCT00539383

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Canc…

This is a phase 1, multi-centre, sequential cohort, open-label, dose-escalation study of the safety, tolerability, and PK of ANG1005 in patients with solid tumo…

United States56 participantsStarted 2007-10

Treatment: ANG1005